Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years
Clinical trial NCT04869982 · COMPLETED
Trial details
- NCT number
- NCT04869982
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-14
- Primary completion
- 2023-04-20
- Enrollment
- 6138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.